2017 Annual Meeting

American Society for Investigative Pathology

March 5 2017, 1:30pm to 5:00pm

Description

American Society for Investigative Pathology

The Liquid Biopsy: Future Applications for the Pathologist Buckle Up, It May Be a Bumpy Ride!

Sunday, March 5, 2017
1:30 PM 5:00 PM
CC 302 AB

Session Credits: 3 CME and 3 SAMs

Moderators: Maria J. Merino, MD, National Institutes of Health, Bethesda, MD
Danny A. Milner, MD, MSc, American Society for Clinical Pathology, Chicago, IL
Mark E. Sobel, MD, PhD, American Society for Investigative Pathology, Bethesda, MD

Course Description:
The integration of anatomic, molecular, and genomic pathology into surgical pathology practice is conspicuous in oncology, where definition of molecular pathways important for specific tumors has enabled development of new biomarkers and innovative approaches to the detection of cancer and metastases. The so-called “liquid biopsy” includes a wide array of new technologies, including tumor-derived tumor vesicles and aptamer probes. The surgical pathologist will need to understand these new technologies and be aware of their advantages and pitfalls as they are applied into practice.

Upon completion of this educational activity, participants should be able to:

  • Describe the new technologies associated with the liquid biopsy
  • Understand how aptamer probes can aide in the detection of circulating tumor cells
  • Describe the role of tumor-derived exosomes

Agenda

1:30 PM

Introduction to the ASIP Companion Meeting
Mark E. Sobel, MD, PhD, American Society for Investigative Pathology, Bethesda, MD

1:35 PM

The Liquid Biopsy: Introduction and Overview
Karen L. Kaul, MD, PhD Northshore University Health System, Evanston IL

2:15 PM

Liquid Biopsies in Lung Cancer
Lynette M. Sholl, MD, Brigham & Women’s Hospital, Boston, MA

3:00 PM

Detection and Analysis of Tumor-Derived Extracellular Vesicles
Jennifer Jones, MD, PhD, National Cancer Institute, Bethesda, MD

3:40 PM

A New Molecular Probe for Rapid Detection of Circulating Tumor Cells in Whole Blood
Youli Zu, MD, Houston Methodist Hospital, Houston, TX

4:20 PM

Final Thoughts on the Liquid Biopsy
Maria J. Merino, MD, National Cancer Institute, Bethesda, MD

Meetings

home-circle-inset-1
view more